Developer docs
API playgroundTry for free, no card

Search company profiles

Quantum Surgical

Full company profile

uuid0000l1v

Namestring
Quantum Surgical
Legal namestring
Quantum Surgical SAS
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Quantum Surgical is a French medical robotics company founded in 2017 in Montpellier that develops and commercializes the Epione robotic-assisted percutaneous ablation platform for minimally invasive cancer treatment. Epione integrates a 6-degree-of-freedom robotic arm, navigation system, camera, and AI-powered planning/confirmation software to assist interventional radiologists in performing image-guided tumor ablation across liver, kidney, lung, pancreatic, and bone indications using CT image guidance and supporting multiple energy modalities (microwave, radiofrequency, cryoablation, irreversible electroporation). The platform is CE marked for abdomen, chest, and musculoskeletal structures and FDA 510(k) cleared for abdominal ablation.

The company sells Epione as capital equipment with associated software licenses, installation/training services, and multi-year support contracts to large hospital systems and specialized cancer centers through direct enterprise field sales in Europe and the US, supplemented by a Unison Healthcare Group distribution partnership in Taiwan. Following the February 2026 acquisition of NeuWave Medical from Johnson & Johnson, Quantum Surgical and NeuWave operate as subsidiaries under newly created Precision IO Group Inc., led by CEO Kurt Azarbarzin, combining Epione's robotic platform with NeuWave's microwave ablation technology that is deployed in over 70% of top US cancer centers. Quantum Surgical has raised €40 million in Series A funding led by Ally Bridge Group plus €30 million in EIB debt financing, holds 25+ patents, and has installed Epione in 20+ cancer centers with 1,700+ patients treated worldwide.

Short descriptiontext

Quantum Surgical develops the Epione robotic-assisted percutaneous ablation platform that helps interventional radiologists treat liver, kidney, lung, and bone tumors minimally invasively. The company sells capital equipment, software, and services to hospitals and cancer centers across Europe, the US, and Asia, and now operates alongside NeuWave Medical under Precision IO Group.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMontpellier, France
HQ citystring
Montpellier
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
robotic surgery systems, percutaneous tumor ablation, interventional oncology, image-guided ablation, medical robotics devices
Industry4 codes
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAHAFAD
Electrophysiology Mapping & Ablation Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
NAICS code3 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Interventional Oncology / Surgical Robotics
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Epione Robotic Platform Sales
TypeHardware Sales
Description

Sale of the Epione robotic system to hospitals and cancer centers. The platform is sold as capital equipment with associated software licenses and support contracts. Installation, training, and ongoing maintenance services are provided.

quantumsurgical.com
2NeuWave Ablation Products
TypeHardware Sales
Description

Sale of microwave ablation technology including generators, antennas, and disposables. NeuWave products are distributed in France, Germany, UK through Quantum Surgical and directly in the US market.

quantumsurgical.com
3Service and Support Contracts
TypeSubscription Recurring
Description

Ongoing support, maintenance, and training services for installed base of Epione and NeuWave customers.

quantumsurgical.com
4Professional Services
TypeProfessional Services
Description

Training, installation, and clinical support services for hospital customers implementing robotic ablation programs.

quantumsurgical.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1Direct enterprise sales to hospitals
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is quote-based through direct sales engagement with hospital procurement and clinical teams. No public pricing information available.

quantumsurgical.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Epione
Description

Robotic-assisted percutaneous ablation platform for tumor treatment, indicated for abdomen, chest and musculoskeletal structures (CE marked) and abdominal ablation (FDA cleared).

quantumsurgical.com
+1 more record
Core offering1 text field

Quantum Surgical designs, manufactures, and commercializes the Epione robotic-assisted percutaneous ablation platform for interventional radiology. The system combines a robotic arm, image-guided navigation software, and ablation instrument integration to enable interventional radiologists to plan, target, and treat tumors in the abdomen and lungs via minimally invasive needle-based ablation. The company also markets the NeuWave Microwave Ablation System and the HYGIE Health Data Warehouse research infrastructure acquired through its integration into the Precision IO Group.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Over 1,700 patients treated worldwide with Epione robotic platform
+4 more records
Product overview1 text field

Quantum Surgical offers a unified product portfolio centered on the Epione robotic-assisted percutaneous ablation platform. Epione serves as the core product—a robotic arm with navigation, planning software, and confirmation software that integrates all steps of percutaneous tumor ablation (planning, targeting, ablation, confirmation) in a single platform. The company acquired NeuWave Medical in February 2026, adding its market-leading microwave ablation system as a complementary technology used in over 70% of top US cancer centers. Both operate under Precision IO Group Inc. parent company. Epione is indicated for abdomen, chest, and musculoskeletal structures (CE marked) and abdominal ablation (FDA cleared), supporting multiple ablation modalities including microwave ablation (MWA), radiofrequency ablation (RFA), cryoablation, and irreversible electroporation (IRE).

Product and service3 records
1Epione Robotic-Assisted Percutaneous Ablation Platform
CategoryRobotic-Assisted Percutaneous Ablation System
Description

The Epione platform is a robotic-assisted percutaneous ablation system for interventional radiologists, combining robotic needle positioning, 3D treatment planning, and image-guided navigation to plan, target, and ablate tumors in the abdomen and lungs under CT or cone-beam CT guidance. It is sold to hospitals and cancer centers performing interventional oncology procedures.

2NeuWave Microwave Ablation System
CategoryMicrowave Tumor Ablation Device
Description

The NeuWave Microwave Ablation System is a microwave ablation device used by interventional radiologists to thermally ablate soft-tissue tumors. It is sold to hospitals and interventional radiology departments, with distribution across the United States, France, Germany, and the United Kingdom.

3HYGIE Health Data Warehouse
CategoryClinical Research Data Infrastructure
Description

HYGIE is a clinical data warehouse and research infrastructure supporting multi-center clinical data aggregation for percutaneous ablation procedures, used internally and with clinical partners to generate evidence on robotic-assisted ablation outcomes and to support regulatory and clinical publications.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
1Precision IO Group Inc.
Strategic tierCoreTypeOthersAnnounced on2026-02-24
Description

Newly created parent company combining Quantum Surgical and NeuWave Medical as subsidiaries. Led by medtech veteran Kurt Azarbarzin as CEO. Backed by investment from Ally Bridge Group. The group's ambition is to become a leader in interventional radiology with focus on precision and remote procedures.

globenewswire.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-24
Description

Acquired from Johnson & Johnson, NeuWave is a medical device company with microwave ablation technology used in 70% of top US cancer centers. Now operates as subsidiary of Precision IO Group alongside Quantum Surgical. Acquisition combines Epione robotic platform with NeuWave's market-leading ablation technology.

Strategic tierMinorTypeOthersAnnounced on2026-02-24
Description

Served as exclusive financial advisor to Quantum Surgical for the NeuWave Medical acquisition.

Strategic tierMinorTypeOthersAnnounced on2026-02-24
Description

Legal advisor to Quantum Surgical for the NeuWave Medical acquisition transaction.

5PreciseOnco Consortium
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-02-04
Description

EU-funded research consortium (€14.9M IHI grant, €23.9M total budget) coordinated by Philips. Quantum Surgical participates alongside Philips, IGEA, research institutes, and European hospitals to advance precision cancer treatment through spectral imaging, robotic guidance, and AI technologies over a five-year program.

quantumsurgical.com
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2026-02-04
Description

Coordinator of PreciseOnco research consortium. Leading medical technology company partnering on spectral imaging and AI-guided integrated technologies for precision cancer care.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-02-04
Description

Industry partner in PreciseOnco consortium contributing to precision cancer treatment technologies including electrochemotherapy.

8Unison Healthcare Group
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-03-20
Description

Taiwanese distributor partnership for Epione commercialization. Unison Healthcare Group distributes multiple surgical robots in Taiwan and has B Corp certification. Partnership extends Quantum Surgical's presence in Taiwan market.

quantumsurgical.com
9Scientific Advisory Board Members
Strategic tierMajorTypeOthersAnnounced on2025-02-27
Description

International experts in interventional oncology providing clinical guidance and support: Dr. Govindarajan Narayanan (Baptist Health), Dr. Steven D. Colquhoun (Wellstar MCG Health), Dr. Thierry De Baère (Gustave Roussy), Dr. Laurent Milot (Hospices Civils de Lyon), Dr. Luigi Solbiati (Humanitas University), Dr. Sean Tutton (UC San Diego).

quantumsurgical.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Dominant surgical robotics incumbent (da Vinci platform) with extensive global hospital footprint and strong KOL relationships. While focused on laparoscopic surgery, Intuitive's installed base and R&D capacity make it a long-term competitive threat as interventional oncology robotics expands.

TypeDirect peer
Description

Pure-play interventional oncology and vascular device company offering microwave and radiofrequency ablation systems, including the Solero and Acculis platforms. Directly comparable as a tumor ablation capital equipment vendor serving interventional radiology departments.

TypeBroad incumbent
Description

Major medtech company with significant interventional oncology and percutaneous ablation portfolio (formerly including the NeuWave microwave ablation business before divesting). Competes broadly in the same hospital call points and could re-enter robotic ablation guidance.

TypeBroad incumbent
Description

Owns the MAKO surgical robotics platform and acquired Mobius Imaging/Cardan Robotics for image-guided interventional capabilities. Comparable as a surgical robotics incumbent expanding into image-guided and interventional procedures.

TypeBroad incumbent
Description

Owner of the Hugo robotic-assisted surgery platform and Mazor spine robotics. As a broad medtech incumbent pushing into surgical robotics and interventional procedures, Medtronic competes for hospital capital equipment budgets and interventional radiology share of mind.

TypeEmerging player
Description

Acquired Corindus, a robotic-assisted vascular intervention platform. Comparable as a robotic guidance system for image-guided minimally invasive procedures, though currently focused on vascular rather than oncology applications.

TypeEmerging player
Description

Developer of the TULSA-PRO robotic transurethral ultrasound ablation system for prostate tissue, plus Sonalleve MR-HIFU platform. Comparable as a focused image-guided ablation robotics company targeting oncology indications with novel energy modalities.

TypeEmerging player
Description

Focused ablation device company with Focal One high-intensity focused ultrasound (HIFU) robotic platform for prostate cancer and ExactVu micro-ultrasound. Comparable as a specialty robotic ablation company addressing oncology indications in hospital settings.

TypeBroad incumbent
Description

Owner of MONARCH robotic bronchoscopy platform (Auris Health) and previous owner of NeuWave (divested to Quantum Surgical in Feb 2026). Highly comparable as the seller of one of Quantum Surgical's core acquired assets and as an adjacent robotic interventional oncology competitor.

TypeDirect peer
Description

Interventional radiology and oncology device company offering ablation systems, microcatheters, and embolization products. Comparable as a direct supplier of percutaneous tumor ablation capital equipment and consumables to interventional radiology departments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Quantum Surgical

Interventional Oncology / Surgical Roboticsquantumsurgical.com

Quantum Surgical develops the Epione robotic-assisted percutaneous ablation platform that helps interventional radiologists treat liver, kidney, lung, and bone tumors minimally invasively. The company sells capital equipment, software, and services to hospitals and cancer centers across Europe, the US, and Asia, and now operates alongside NeuWave Medical under Precision IO Group.

What Quantum Surgical does

Quantum Surgical is a French medical robotics company founded in 2017 in Montpellier that develops and commercializes the Epione robotic-assisted percutaneous ablation platform for minimally invasive cancer treatment. Epione integrates a 6-degree-of-freedom robotic arm, navigation system, camera, and AI-powered planning/confirmation software to assist interventional radiologists in performing image-guided tumor ablation across liver, kidney, lung, pancreatic, and bone indications using CT image guidance and supporting multiple energy modalities (microwave, radiofrequency, cryoablation, irreversible electroporation). The platform is CE marked for abdomen, chest, and musculoskeletal structures and FDA 510(k) cleared for abdominal ablation.

The company sells Epione as capital equipment with associated software licenses, installation/training services, and multi-year support contracts to large hospital systems and specialized cancer centers through direct enterprise field sales in Europe and the US, supplemented by a Unison Healthcare Group distribution partnership in Taiwan. Following the February 2026 acquisition of NeuWave Medical from Johnson & Johnson, Quantum Surgical and NeuWave operate as subsidiaries under newly created Precision IO Group Inc., led by CEO Kurt Azarbarzin, combining Epione's robotic platform with NeuWave's microwave ablation technology that is deployed in over 70% of top US cancer centers. Quantum Surgical has raised €40 million in Series A funding led by Ally Bridge Group plus €30 million in EIB debt financing, holds 25+ patents, and has installed Epione in 20+ cancer centers with 1,700+ patients treated worldwide.

Quantum Surgical firmographics

Firmographics
Name
Quantum Surgical
Legal name
Quantum Surgical SAS
Website
https://quantumsurgical.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
101–250 employees
Short description
Quantum Surgical develops the Epione robotic-assisted percutaneous ablation platform that helps interventional radiologists treat liver, kidney, lung, and bone tumors minimally invasively. The company sells capital equipment, software, and services to hospitals and cancer centers across Europe, the US, and Asia, and now operates alongside NeuWave Medical under Precision IO Group.
Ownership category
akta.pro rank

Quantum Surgical industry classification

Industry
Product category
Interventional Oncology / Surgical Robotics
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHABAG
Interventional Radiology & Image-Guided Therapy Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAHAFAD
Electrophysiology Mapping & Ablation Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

  • Robotic surgery systems
  • Percutaneous tumor ablation
  • Interventional oncology
  • Image-guided ablation
  • Medical robotics devices

Where Quantum Surgical is headquartered

Location

Headquarters

HQ city
Montpellier
HQ country
France
HQ region
Europe

Offices2 records

Markets served

Quantum Surgical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Epione Robotic Platform Sales: Sale of the Epione robotic system to hospitals and cancer centers. The platform is sold as capital equipment with associated software licenses and support contracts. Installation, training, and ongoing maintenance services are provided.
  2. NeuWave Ablation Products: Sale of microwave ablation technology including generators, antennas, and disposables. NeuWave products are distributed in France, Germany, UK through Quantum Surgical and directly in the US market.
  3. Service and Support Contracts: Ongoing support, maintenance, and training services for installed base of Epione and NeuWave customers.
  4. Professional Services: Training, installation, and clinical support services for hospital customers implementing robotic ablation programs.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractDirect enterprise sales to hospitals

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Quantum Surgical product offering

Product offering

Core offering

Quantum Surgical designs, manufactures, and commercializes the Epione robotic-assisted percutaneous ablation platform for interventional radiology. The system combines a robotic arm, image-guided navigation software, and ablation instrument integration to enable interventional radiologists to plan, target, and treat tumors in the abdomen and lungs via minimally invasive needle-based ablation. The company also markets the NeuWave Microwave Ablation System and the HYGIE Health Data Warehouse research infrastructure acquired through its integration into the Precision IO Group.

Product overview

Quantum Surgical offers a unified product portfolio centered on the Epione robotic-assisted percutaneous ablation platform. Epione serves as the core product—a robotic arm with navigation, planning software, and confirmation software that integrates all steps of percutaneous tumor ablation (planning, targeting, ablation, confirmation) in a single platform. The company acquired NeuWave Medical in February 2026, adding its market-leading microwave ablation system as a complementary technology used in over 70% of top US cancer centers. Both operate under Precision IO Group Inc. parent company. Epione is indicated for abdomen, chest, and musculoskeletal structures (CE marked) and abdominal ablation (FDA cleared), supporting multiple ablation modalities including microwave ablation (MWA), radiofrequency ablation (RFA), cryoablation, and irreversible electroporation (IRE).

Differentiator

Problem solved

Functional benefit

Brands

  • Epione: Robotic-assisted percutaneous ablation platform for tumor treatment, indicated for abdomen, chest and musculoskeletal structures (CE marked) and abdominal ablation (FDA cleared).
  • HYGIE

Products and services

  • Epione Robotic-Assisted Percutaneous Ablation Platform The Epione platform is a robotic-assisted percutaneous ablation system for interventional radiologists, combining robotic needle positioning, 3D treatment planning, and image-guided navigation to plan, target, and ablate tumors in the abdomen and lungs under CT or cone-beam CT guidance. It is sold to hospitals and cancer centers performing interventional oncology procedures.
  • NeuWave Microwave Ablation System The NeuWave Microwave Ablation System is a microwave ablation device used by interventional radiologists to thermally ablate soft-tissue tumors. It is sold to hospitals and interventional radiology departments, with distribution across the United States, France, Germany, and the United Kingdom.
  • HYGIE Health Data Warehouse HYGIE is a clinical data warehouse and research infrastructure supporting multi-center clinical data aggregation for percutaneous ablation procedures, used internally and with clinical partners to generate evidence on robotic-assisted ablation outcomes and to support regulatory and clinical publications.

Quantifiable outcome

  • Over 1,700 patients treated worldwide with Epione robotic platform
  • +4 more outcomes

Companies that use Quantum Surgical

Customer profile

Named customers10 records

Segments3 records

Ideal customer profiles1 record

Quantum Surgical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Quantum Surgical partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core, minor and major.

  • Precision IO Group Inc.coreOthers · 24 February 2026Newly created parent company combining Quantum Surgical and NeuWave Medical as subsidiaries. Led by medtech veteran Kurt Azarbarzin as CEO. Backed by investment from Ally Bridge Group. The group's ambition is to become a leader in interventional radiology with focus on precision and remote procedures.
  • NeuWave Medical, Inc.coreStrategic or Co-development Partner · 24 February 2026Acquired from Johnson & Johnson, NeuWave is a medical device company with microwave ablation technology used in 70% of top US cancer centers. Now operates as subsidiary of Precision IO Group alongside Quantum Surgical. Acquisition combines Epione robotic platform with NeuWave's market-leading ablation technology.
  • StifelminorOthers · 24 February 2026Served as exclusive financial advisor to Quantum Surgical for the NeuWave Medical acquisition.
  • McDermott Will & Schulte LLPminorOthers · 24 February 2026Legal advisor to Quantum Surgical for the NeuWave Medical acquisition transaction.
  • PreciseOnco ConsortiummajorStrategic or Co-development Partner · 4 February 2026EU-funded research consortium (€14.9M IHI grant, €23.9M total budget) coordinated by Philips. Quantum Surgical participates alongside Philips, IGEA, research institutes, and European hospitals to advance precision cancer treatment through spectral imaging, robotic guidance, and AI technologies over a five-year program.
  • PhilipsmajorStrategic or Co-development Partner · 4 February 2026Coordinator of PreciseOnco research consortium. Leading medical technology company partnering on spectral imaging and AI-guided integrated technologies for precision cancer care.
  • IGEAminorStrategic or Co-development Partner · 4 February 2026Industry partner in PreciseOnco consortium contributing to precision cancer treatment technologies including electrochemotherapy.
  • Unison Healthcare GroupmajorChannel Partner/ Reseller/ Distributor · 20 March 2025Taiwanese distributor partnership for Epione commercialization. Unison Healthcare Group distributes multiple surgical robots in Taiwan and has B Corp certification. Partnership extends Quantum Surgical's presence in Taiwan market.
  • Scientific Advisory Board MembersmajorOthers · 27 February 2025International experts in interventional oncology providing clinical guidance and support: Dr. Govindarajan Narayanan (Baptist Health), Dr. Steven D. Colquhoun (Wellstar MCG Health), Dr. Thierry De Baère (Gustave Roussy), Dr. Laurent Milot (Hospices Civils de Lyon), Dr. Luigi Solbiati (Humanitas University), Dr. Sean Tutton (UC San Diego).

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Quantum Surgical competitors and assessment

Company assessment

Broad incumbents

  • Intuitive Surgical: Dominant surgical robotics incumbent (da Vinci platform) with extensive global hospital footprint and strong KOL relationships. While focused on laparoscopic surgery, Intuitive's installed base and R&D capacity make it a long-term competitive threat as interventional oncology robotics expands.
  • Boston Scientific: Major medtech company with significant interventional oncology and percutaneous ablation portfolio (formerly including the NeuWave microwave ablation business before divesting). Competes broadly in the same hospital call points and could re-enter robotic ablation guidance.
  • Stryker: Owns the MAKO surgical robotics platform and acquired Mobius Imaging/Cardan Robotics for image-guided interventional capabilities. Comparable as a surgical robotics incumbent expanding into image-guided and interventional procedures.
  • Medtronic: Owner of the Hugo robotic-assisted surgery platform and Mazor spine robotics. As a broad medtech incumbent pushing into surgical robotics and interventional procedures, Medtronic competes for hospital capital equipment budgets and interventional radiology share of mind.
  • Johnson & Johnson MedTech: Owner of MONARCH robotic bronchoscopy platform (Auris Health) and previous owner of NeuWave (divested to Quantum Surgical in Feb 2026). Highly comparable as the seller of one of Quantum Surgical's core acquired assets and as an adjacent robotic interventional oncology competitor.

Direct peers

  • AngioDynamics: Pure-play interventional oncology and vascular device company offering microwave and radiofrequency ablation systems, including the Solero and Acculis platforms. Directly comparable as a tumor ablation capital equipment vendor serving interventional radiology departments.
  • Merit Medical Systems: Interventional radiology and oncology device company offering ablation systems, microcatheters, and embolization products. Comparable as a direct supplier of percutaneous tumor ablation capital equipment and consumables to interventional radiology departments.

Emerging players

  • Siemens Healthineers (Corindus): Acquired Corindus, a robotic-assisted vascular intervention platform. Comparable as a robotic guidance system for image-guided minimally invasive procedures, though currently focused on vascular rather than oncology applications.
  • Profound Medical: Developer of the TULSA-PRO robotic transurethral ultrasound ablation system for prostate tissue, plus Sonalleve MR-HIFU platform. Comparable as a focused image-guided ablation robotics company targeting oncology indications with novel energy modalities.
  • EDAP TMS: Focused ablation device company with Focal One high-intensity focused ultrasound (HIFU) robotic platform for prostate cancer and ExactVu micro-ultrasound. Comparable as a specialty robotic ablation company addressing oncology indications in hospital settings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Quantum Surgical social profiles

Digital presence

Quantum Surgical compliance and trust

Trust signal

Compliance4 records

Quantum Surgical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Quantum Surgical leadership team

Management profile

Number of profiles

Profiles16 records

Quantum Surgical subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Quantum Surgical funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Quantum Surgical M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quantum Surgical

What does Quantum Surgical do?

Quantum Surgical designs, manufactures, and commercializes the Epione robotic-assisted percutaneous ablation platform for interventional radiology. The system combines a robotic arm, image-guided navigation software, and ablation instrument integration to enable interventional radiologists to plan, target, and treat tumors in the abdomen and lungs via minimally invasive needle-based ablation. The company also markets the NeuWave Microwave Ablation System and the HYGIE Health Data Warehouse research infrastructure acquired through its integration into the Precision IO Group.

Is Quantum Surgical a public or private company?

Quantum Surgical is a private company. It is classified as venture growth investor backed and is currently operating.

When was Quantum Surgical founded?

Quantum Surgical was founded in 2017. It employs 101 to 250 people.

Where is Quantum Surgical based?

Quantum Surgical is headquartered in Montpellier, France, in the Europe region.

How does Quantum Surgical make money?

Four revenue lines are on record. Epione Robotic Platform Sales are the primary driver. The others are neuWave Ablation Products, service and Support Contracts and professional Services.

Who are Quantum Surgical's main competitors?

Broad incumbents on record are Intuitive Surgical, Boston Scientific, Stryker, Medtronic and Johnson & Johnson MedTech. Direct peers are AngioDynamics and Merit Medical Systems. Emerging players are Siemens Healthineers (Corindus), Profound Medical and EDAP TMS.

Does Quantum Surgical have an API?

No public API is recorded for Quantum Surgical.

What industry is Quantum Surgical in?

Quantum Surgical's product category is Interventional Oncology / Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Radiology BusinessCompany seeks to become a ‘leader in interventional radiology’ with recent acquisitionMontpellier, France-based Quantum Surgical has reached a deal to acquire NeuWave Medical, a device company previously held by Johnson & Johnson, with both firms to operate as subsidiaries of a newly created parent company called Precision IO Group. The combined group's ambition is to become a leader in interventional radiology, with Quantum bringing its robotics and AI-based Epione platform for tumor ablation and NeuWave contributing its market-leading microwave ablation technology. The acquisition positions the new entity to offer complementary minimally invasive cancer care solutions across precision and remote procedures.Pulse 2.0Quantum Surgical Acquires NeuWave Medical To Expand Tumor Ablation PlatformQuantum Surgical has acquired NeuWave Medical to form a new parent company, Precision IO Group Inc., led by medtech veteran Kurt Azarbarzin as CEO. The transaction combines Quantum Surgical's Epione robotic platform for tumor ablation with NeuWave's microwave ablation technology, which is used in 70% of the top US cancer centers, aiming to expand access to minimally invasive cancer treatments through remote interventions. The acquisition, backed by investment from Ally Bridge Group, positions the combined entity to become a leader in interventional radiology while both companies continue operating independently.FierceBiotechQuantum Surgical snaps up J&J's NeuWave Medical for its microwave ablation technologyQuantum Surgical, a France-based cancer robotics specialist, has acquired Johnson & Johnson's cancer ablation company NeuWave Medical, which will operate as a subsidiary alongside Quantum under a newly formed parent company, Precision IO Group Inc. The acquisition gives Quantum access to NeuWave's microwave ablation platform, currently used by 70% of the top cancer centers in the U.S., which will complement Quantum's existing Epione robotic platform for percutaneous tumor ablations. Financial terms of the deal were not disclosed, and the new parent company will be led by medtech veteran Kurt Azarbarzin.MassDeviceQuantum Surgical acquires Neuwave Medical from J&J to form new surgical robotic ventureQuantum Surgical has acquired Neuwave Medical from Johnson & Johnson to form a new surgical robotic venture under the newly created parent company Precision IO Group Inc. The acquisition grants Quantum access to Neuwave's microwave ablation technology and intellectual property, aiming to combine robotic-assisted capabilities with minimally invasive treatments for cancer. Led by CEO Kurt Azarbarzin, the new entity intends to expand access to remote interventions and precision procedures in interventional oncology.MedTech DiveQuantum Surgical buys J&J’s NeuWaveQuantum Surgical, a medical robotics company based in France, announced that it has acquired NeuWave Medical from Johnson & Johnson. The acquisition supports Quantum's strategy to expand robot-assisted tumor ablation treatments for cancer. J&J had previously planned to discontinue NeuWave, which is widely used in US cancer centers.Medical Device and Diagnostic industryQuantum Surgical Acquires Johnson & Johnson's NeuWaveQuantum Surgical has acquired Johnson & Johnson's NeuWave microwave ablation business for an undisclosed amount, with both companies now operating as subsidiaries under newly created parent company Precision IO Group led by medtech veteran Kurt Azarbarzin. NeuWave, which was slated for discontinuation by Johnson & Johnson's Ethicon (which had acquired it about a decade ago), brings complementary ablation technology that will pair with Quantum's FDA-cleared Epione robotic platform for abdominal ablation procedures. Precision IO Group's stated mission is to break down geographical barriers by enabling remote robotic-assisted percutaneous cancer procedures globally, leveraging world-renowned experts for remote trajectory planning and results assessment.GlobeNewswireQuantum Surgical Announces Acquisition of NeuWave Medical, Inc.Quantum Surgical has acquired NeuWave Medical, Inc., with both companies becoming subsidiaries of newly created parent company Precision IO Group Inc. The acquisition combines Quantum Surgical's Epione robotic platform for tumor ablation with NeuWave's market-leading microwave ablation technology, which is used in 70% of top US cancer centers. Kurt Azarbarzin, a medtech veteran with experience at SurgiQuest, EndoQuest Robotics, and Verb Surgical, has been appointed as CEO of Precision IO Group Inc., which is backed by investment from Ally Bridge Group.SurgicalroboticstechnologyQuantum Surgical Completes Acquisition of NeuWave Medical, Inc.Quantum Surgical has completed the acquisition of NeuWave Medical, Inc., a medical device company whose microwave ablation technology is used in 70% of top US cancer centers, creating a new parent entity called Precision IO Group Inc. The combined company, led by newly appointed CEO Kurt Azarbarzin, brings together Quantum Surgical's robotics and AI platform (Epione) with NeuWave's clinically proven ablation technology under one umbrella. The group aims to become a leader in interventional radiology by leveraging AI, robotics, and remote procedures to expand access to minimally invasive cancer care globally.MaddynessRobotique médicale : Quantum Surgical s’offre une filiale de Johnson & JohnsonQuantum Surgical, a Montpellier-based medical robotics company, has acquired NeuWave Medical, an American subsidiary of Johnson & Johnson, to expand into the US market with microwave ablation technology used in 70% of major US cancer centers. The two companies will operate independently under a newly created parent company called Precision IO Group, headquartered in Miami with 250 employees and led by medtech veteran Kurt Azarbarzin. Quantum Surgical's Epione robot, which has already treated over 1,400 patients in Europe and the US for abdominal and lung cancers, will serve as the cornerstone of this new global entity focused on robotic tumor ablation treatments.